Detalhe da pesquisa
1.
Immunogenicity and Safety of a Hexavalent DTwP-IPV-HB-PRP~T Vaccine Versus Separate DTwP-HB-PRP~T, bOPV, and IPV Vaccines Administered at 2, 4, 6 Months of Age Concomitantly With Rotavirus and Pneumococcal Conjugate Vaccines in Healthy Infants in Thailand.
Pediatr Infect Dis J
; 42(8): 711-718, 2023 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37257121
2.
Safety and immunogenicity of a new formulation of a pentavalent DTwP-HepB-Hib vaccine in healthy Indian infants-A randomized study.
PLoS One
; 18(8): e0284898, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37582114
3.
Antibody Persistence Following Administration of a Hexavalent DTwP-IPV-HB-PRP~T Vaccine Versus Separate DTwP-HB-PRP~T and IPV Vaccines and Safety and Immunogenicity of a Booster Dose of DTwP-IPV-HB-PRP~T Administered With an MMR Vaccine in Healthy Infants in India.
Pediatr Infect Dis J
; 42(12): 1128-1135, 2023 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37851978
4.
Bivalent oral cholera vaccine in participants aged 1 year and older in the Dominican Republic: A phase III, single-arm, safety and immunogenicity trial.
Hum Vaccin Immunother
; 14(6): 1403-1411, 2018 06 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-29470934